Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF

NCT: NCT06344871 · TERMINATED

NCT IDNCT06344871
StatusTERMINATED
Start Date2024-03-13
Completion2026-08-06
SponsorPositrigo AG (INDUSTRY)
First posted
Last updated

Brief Summary

The "NeuroLF prototype" is a small aperture PET scanner. The NeuroLF prototype will be used with patients, which have just finished their regularly scheduled PET examination on a clinical whole body PET system. The radioactive tracer used for this procedure will still be active. This remaining acitivity will be used for an image acquisition with the NeuroLF prototype without the need for an additional radioactive tracer dose. The control intervention is be a brain PET scan as part of standard clinical routine. It will be done immediately before the scan on the NeuroLF prototype.

Frequently Asked Questions

What is Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF?

Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF is a clinical trial registered under NCT06344871. Current status: TERMINATED.

What is the status of NCT06344871?

The current status of NCT06344871 (Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF) is: TERMINATED.

When did Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF start?

Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF started on 2024-03-13.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.